For Sale BETTER B30P CPAP

This item is not for sale within the USA

Nowadays,COVID-19 which causedby the novel coronavirus outbreaks worldwide.The virus will quickly invadehuman lung cells and cause pneumonia, which will cause severe lower respiratory tract diseases, such as acute lung injuryand respiratory distress syndrome. Some critical pati-entmay even have symptoms such as respiratory failure, refractory hypoxemia,shock,mul-tiple organ failure,and coagulopathy.
For COVID-19,ventilator is one of the most effective treatments in the absence of specific drugs.Under ventilated, the blood oxygen of patient can be effectively improved and the mortality rate can be reduced.

How to avoid nosocomial infections with non-invasive？

Filter needs to pay attention to the problem of increased resistance to water overload.

The increased resistance needs to be replaced at any time!

B-30P can be used in para treatment for patients with COVID-19.
Fe a t u r e
1. Small size, color LCD display
2. Portable and easy to operate
3. Can be equipped with trolleys
4. Can be equipped with independent humidifier
5. Can be equipped with SPO2 module
6. Real-time display and monitoring of clinical
use data of patients;
7. Connect to Low-flow oxygen, for air-oxygen mixing;
8. With VAF (Vital assurance function);
9. Max.IPAP: 30cmH2O;
10. Ventilation mode: CPAP, S, ST, T, APCV.

Product name： Non-invasive ventilator
Model： ResPlus®B-30P
Screen： 3.5'' colorful LCD
Respiratory mode： CPAP、S、ST、T、APCV
Weight： 2.2Kg
Dimension： 280mm*200mm*112mm
Noise Level：<30dBA
Parameters
IPAP(cmH2O)：4-30cmH2O EPAP(cmH2O)： 4-25cmH2O
Isens：Auto,1-6 level Esens： Auto,1-6 level
Islop：1-6 level
InspTime： 0.5-4s Max-InspTime： 0.5-4s Min-InspTime： 0.5-4s
BPM： 3-40bpm
Humidifier： 0-5 level
Auto-On： On/Off
Auto-Off： On/Off
Auto-air compensation： Available
Auto-adjustment altitude： Available
VAF settings： Available
Target VT： 50-2000ml
Ramp： 0-60 min
Data storage： TF card

Return Policy

Items are sold as-is with no returns or refunds available unless explicitly stated.